BREAST CANCER

Refine Results:
All Categories Epidemiology and Etiology (624) Prevention and Screening (456) Diagnosis and Staging (718) Treatment (1547) Supportive Oncology (177)

CME

CaseLine: HER2-Positive Breast Cancer
An interactive CME program provided by Educational Concepts Group, LLC
OncologySTAT CME
Monica Visit 2: A 36-Year-Old Female with Early Stage Breast Cancer, Returning for Follow-up
An interactive CME program powered by Real CME
OncologySTAT CME
Clinically Challenging Case Series: Breast Cancer-Related Bone Disease
OncologySTAT CME
Monica Visit 1: A 36-Year-Old Female with Early Stage Breast Cancer
An interactive CME program powered by Real CME
OncologySTAT CME
Karen Visit 2: A 49-Year-Old Female with Early Stage Breast Cancer, Returning for Follow-up
An interactive CME program powered by RealCME
OncologySTAT CME
More CME ›

News

Bevacizumab Boosts Treatment Responses in Early Breast Cancer
Elsevier Global Medical News, 2012 Jan 25, S Worcester
Trastuzumab Bests Lapatinib for HER2 Breast Cancer
Elsevier Global Medical News, 2012 Jan 17, S Worcester
Safety of Skin-Sparing Mastectomy Confirmed Short-Term
Elsevier Global Medical News, 2012 Jan 10, D Mahoney
Less Trastuzumab Cardiotoxicity in Beta-Blocker Users
Elsevier Global Medical News, 2012 Jan 4, B Jancin
Program Curbs Shoulder Morbidity Post Breast Cancer
Elsevier Global Medical News, 2012 Jan 4, B Jancin
More News ›

Journal Scans: Research

High Non-Compliance in the Use of Letrozole After 2.5 Years of Extended Adjuvant Endocrine Therapy. Results From the IDEAL Randomized Trial
Eur J Surg Oncol, 2012 Feb 1, DBY Fontein, et al
Free Journal Content
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
N Engl J Med, 2012 Jan 26, G von Minckwitz, et al
EXPERT COMMENTARY
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
N Engl J Med, 2012 Jan 26, H Bear, et al
Neoadjuvant Anastrozole Versus Tamoxifen in Patients Receiving Goserelin for Premenopausal Breast Cancer (STAGE): A Double-Blind, Randomised Phase 3 Trial
Lancet Oncol, 2012 Jan 20, N Masuda, et al
Lapatinib With Trastuzumab for HER2-Positive Early Breast Cancer (NeoALTTO): A Randomised, Open-Label, Multicentre, Phase 3 Trial
Lancet, 2012 Jan 16, J Baselga, et al
More Journal Scans: Research ›

Journal Scans: Review

Target Therapy in Elderly Breast Cancer Patients
Crit Rev Oncol Hematol, 2012 Jan 16, P Carli, et al
Free Journal Content
Breast Cancer Occurred After Hodgkin's Disease: Clinico-Pathological Features, Treatments and Outcome: Analysis of 214 Cases
Crit Rev Oncol Hematol, 2012 Jan 1, B Cutuli, et al
Free Journal Content
Clinical Review - Breast Adenoid Cystic Carcinoma
Breast, 2011 Dec 9, N Boujelbene, et al
Free Journal Content
Management of Non Metastatic Phyllodes Tumors of the Breast: Review of the Literature
Surg Oncol, 2011 Dec 1, P Khosravi-Shahi
Treatment of Metastatic Breast Cancer: State-of-the-Art, Subtypes and Perspectives
Crit Rev Oncol Hematol, 2011 Dec 1, NS El Saghir, et al
More Journal Scans: Review ›

Expert Opinion

Ask the Expert: Applying BOLERO-2 to the “Hormone-Refractory” Patient
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: What’s the Role for Post-Mastectomy Radiation and Chemotherapy in Node-Positive Breast Cancer?
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: Should I Use Adjuvant Therapy in DCIS?
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: Optimal Chemotherapy for Metastatic TNBC?
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: Optimal Treatment for ER+, HER2− Early-Stage Breast Cancer in Males
2012 Jan 30, Clifford Hudis, et al
More Expert Opinion ›

Chemotherapy Regimens

Hormone therapy (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Trastuzumab, vinorelbine (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TH (paclitaxel, trastuzumab [Herceptin])
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TC (docetaxel, cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TAC (doxetaxel, doxorubicin [Adriamycin], cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Conference Coverage

2011 San Antonio Breast Cancer Symposium
Dec 6-10 2011 San Antonio, et al
2011 Breast Cancer Symposium
Sept 8-10 2011 San Francisco, et al
33rd Annual San Antonio Breast Cancer Symposium
Dec 8-12 2010 San Antonio, et al

Videos

Personalized Medicine: A Long Way to Go
EJC News Focus, 2011 Nov 1
Breast Cancer Drug T-DM1 Shows Promise in Trial
Elsevier Global Medical News, 2011 Oct 13, K Wachter
Therapy Didn’t Increase Postmenopausal Breast Density
Elsevier Global Medical News, 2011 Oct 3
Taking Pills to Prevent Breast Cancer
Elsevier Global Medical News, 2011 Jun 5
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
More Videos ›

Summary of Key Points

Cancer of the Breast
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: Breast Cancer

Summary information about breast cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Read more ›

Commentary

Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration